| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/02/1999 | WO1999043343A1 Novel peptide copolymer compositions |
| 09/02/1999 | WO1999043342A1 Somatotropin compositions mixed with vitamins |
| 09/02/1999 | WO1999043341A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043328A1 Treatment of hiv infections |
| 09/02/1999 | WO1999043311A2 Conjugated suramin or derivatives thereof with peg, polyaspartate or polyglutamate for cancer treatment |
| 09/02/1999 | WO1999043305A1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 09/02/1999 | WO1999043303A1 Method for producing encased spherical granular grains |
| 09/02/1999 | WO1999043302A1 Stabilizing composition for pharmaceutical dosage forms |
| 09/02/1999 | WO1999043300A1 Butorphanol sustained release formulations |
| 09/02/1999 | WO1999032158A3 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 09/02/1999 | WO1999032085A3 Novel pharmaceutical compositions of uridine triphosphate |
| 09/02/1999 | WO1999030693A3 A double capsule for the administration of active principles in multiple therapies |
| 09/02/1999 | WO1999024075A3 Affinity markers for human serum albumin |
| 09/02/1999 | WO1998040052A9 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/02/1999 | WO1998034632A9 Compounds and compositions for delivering active agents |
| 09/02/1999 | CA2322175A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | CA2321947A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | CA2321932A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | CA2321924A1 Butorphanol sustained release formulations |
| 09/02/1999 | CA2321200A1 Composition for transporting negatively charged substances |
| 09/02/1999 | CA2320764A1 Treatment of hiv infections |
| 09/02/1999 | CA2320289A1 Novel peptide copolymer compositions |
| 09/02/1999 | CA2284838A1 Somatotropin compositions mixed with vitamins |
| 09/01/1999 | EP0938902A1 Human growth hormone-containing aqueous pharamceutical composition |
| 09/01/1999 | EP0938900A1 Preventives/remedies for stomatitis |
| 09/01/1999 | EP0938896A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 09/01/1999 | EP0938895A1 New composition to be delivered to the rhinopharyngeal mucose, particularly pernasal |
| 09/01/1999 | EP0938889A2 Use of polyurethane in hair fixative preparations as well as in binding compositions for the pharmaceutical industrie and in coating agents of the textile and paper industries |
| 09/01/1999 | EP0938580A1 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure |
| 09/01/1999 | EP0938549A1 Polymer-protein composites and methods for their preparation and use |
| 09/01/1999 | EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 09/01/1999 | EP0938345A1 Aqueous-based pharmaceutical composition |
| 09/01/1999 | EP0938343A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 09/01/1999 | EP0938342A2 Injection implant |
| 09/01/1999 | EP0938341A2 Compositions and methods for altering the biodistribution of biological agents |
| 09/01/1999 | EP0938340A2 Method for preparing bioactive polymers |
| 09/01/1999 | EP0938339A1 Formulations for topical use |
| 09/01/1999 | EP0938338A1 Carrier composition for influencing the tight junction permeability |
| 09/01/1999 | EP0938331A1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 09/01/1999 | EP0938302A1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 09/01/1999 | EP0938301A1 Directly compressible lactitol and method |
| 09/01/1999 | EP0938300A2 Substituted amylose as a matrix for sustained drug release |
| 09/01/1999 | EP0938297A1 Immunomodulatory formulation |
| 09/01/1999 | EP0938295A1 An orally administrable, paste-like composition for veterinary use, a method for the preparation thereof, and the use of an oily vehicle for the manufacture of such composition |
| 09/01/1999 | EP0938268A1 Edible preservative and acidulant composition |
| 09/01/1999 | EP0760681B1 Modification of clostridial toxins for use as transport proteins |
| 09/01/1999 | EP0721348B1 Monoglyceride/lactate ester permeation enhancer |
| 09/01/1999 | EP0706382B1 Therapeutic preparation for inhalation |
| 09/01/1999 | EP0626862B1 Drug system comprising a gel matrix containing an immobilized drug |
| 09/01/1999 | CN1227502A Improvements in or relating to concrast agents |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1227500A Process for producing drug complexes |
| 09/01/1999 | CN1227499A Drug complexes |
| 09/01/1999 | CN1227498A 医用粉末 Medical powder |
| 09/01/1999 | CN1227495A Compositions of plant carbohydrates as dietary supplements |
| 09/01/1999 | CN1227493A The use of heparin or heparan sulfate in combination with chitosan for prevention or treatment of infections caused by herpes virus |
| 09/01/1999 | CN1227465A Method for control of infestations of honeybee colonies |
| 09/01/1999 | CN1044911C Method for preparing prodrug |
| 08/31/1999 | US5945514 Mannose binding lectin bonded through hydrophylic high molecular weight chain to hydrophobic molecular weight chain; aerosols, creams, lotions for prophylactic use against human immunodeficiency viruses and others |
| 08/31/1999 | US5945510 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 08/31/1999 | US5945447 Shelf life |
| 08/31/1999 | US5945420 Immunopotentiating and infection protective agent and production thereof |
| 08/31/1999 | US5945411 Chemoprevention of metachronous adenomatous colorectal polyps |
| 08/31/1999 | US5945405 Crystal form O of clarithromycin |
| 08/31/1999 | US5945402 Human relaxin formulation |
| 08/31/1999 | US5945400 Nucleic acid-containing composition, preparation and use thereof |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945129 Process for the production of an infusion or dialysis solution containing bicarbonate |
| 08/31/1999 | US5945128 Process to manufacture implants containing bioactive peptides |
| 08/31/1999 | US5945127 Storage-stable drug form |
| 08/31/1999 | US5945125 Consists of a single homogenous mixture of a drug selected from nifedipine, diclofenac sodium, salicylic acid, theophylline anhydrous etc. and an excipient comprising polyethylene oxide and lubricant |
| 08/31/1999 | US5945122 Liposomes containing a cisplatin compound |
| 08/31/1999 | US5945117 Treatment of female sexual dysfunction |
| 08/31/1999 | US5945115 Polymeric compositions useful as controlled release implants |
| 08/31/1999 | US5945100 Tumor delivery vehicles |
| 08/31/1999 | US5945098 Stable intravenously-administrable immune globulin preparation |
| 08/31/1999 | US5945033 Albumin, hemoglobin mixture; stability |
| 08/31/1999 | US5945032 Bactericides, disinfectants, hair cosmetics |
| 08/31/1999 | US5944754 Generation of new tissues on surfaces using hydrogels for cells |
| 08/31/1999 | CA2149765C Sequence-specific binding polymers for duplex nucleic acids |
| 08/31/1999 | CA2110988C Sequence-specific binding polymers for duplex nucleic acids |
| 08/31/1999 | CA2008504C Cryoprotectant sorbitol crystal spherules |
| 08/31/1999 | CA2007334C Anti-ulcer composition |
| 08/26/1999 | WO1999042597A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor |
| 08/26/1999 | WO1999042147A1 Biodegradable shape memory polymers |
| 08/26/1999 | WO1999042138A1 The use of bjerknes forces to manipulate contrast agents |
| 08/26/1999 | WO1999042136A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 08/26/1999 | WO1999042135A1 Micronutrient-dispensing device and method |
| 08/26/1999 | WO1999042134A2 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders |
| 08/26/1999 | WO1999042125A1 Pharmaceutical formulation of a didemnin compound |
| 08/26/1999 | WO1999042114A1 Method for producing a support and storage material for plants and their active ingredients, production of liquids from this material and use of said liquids as therapeutic, cosmetic or cleansing agents |
| 08/26/1999 | WO1999042113A1 Composition and method for the treatment of bladder cancer |
| 08/26/1999 | WO1999042111A1 High-energy cyclodextrin complexes |
| 08/26/1999 | WO1999042110A1 Regulation of estrus and ovulation in gilts |
| 08/26/1999 | WO1999042096A1 Composition comprising theanine |
| 08/26/1999 | WO1999042091A2 Use of polycations as endosomolytic agents |
| 08/26/1999 | WO1999042086A1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 08/26/1999 | WO1999042085A1 Erythropoietin liposomal dispersion |
| 08/26/1999 | WO1999031060A3 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 08/26/1999 | WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |